We believe that evidence-based advocacy is the best way to move bladder cancer patient experience and care forward in a positive direction.
As a global organisation, we engage strategic partners and policy makers to ensure bladder cancer is at the top of the global health policy agenda.
Our goal is to bring bladder cancer to the top of the global health policy agenda, and we do this by communicating the key challenges faced by the bladder cancer patient community at the policy-level to drive concrete change.
We work to bring attention to the needs of patients throughout the entirety of care – from prevention, to diagnosis, access to information, support, treatment and care, quality of life and survivorship. We also advocate for better research to improve our knowledge and understanding of bladder cancer.
We work together with our members and affiliates to support national advocacy efforts, develop key messages, and exchange experiences on what works well, and what doesn’t. We also help to build the capacity of our members to advocate for access to the best possible patient care, support and information.
Finally, we partner with a range of different organisations and stakeholders – including patient organisations, healthcare professionals, the private sector, academics and researchers, policymakers and other global patient organisations – to maximise the impact that we can have in our advocacy activities.
300 cancer organisations express commitment and readiness to support governments in addressing Covid-19 challenges in an effort to help people affected by cancer, including bladder cancer, around the world.Learn more
New report highlights the challenges faced by charitable organisations who provide a wide range of services for cancer patients and their community, including funding of research and health professional education.Learn more
Do you have compelling patient research insights in bladder cancer diagnostics, treatments or follow-ups? Your work deserves a wider audience – submit it for the EAU21 Patient Poster Track.Learn more